FDA
-
-
-
-
-
-
-
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
-
-
-
-
-
-
-
PerkinElmer (PKI) Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel
-
-
-
-
-
-
-
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups
-
-
-
-
-
-
-
PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening
-
-
-
-
-
-
-
PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling to Test Symptomatic and Asymptomatic Individuals
-
-
-
-
-
-
-
PerkinElmer Releases New Dried Blood Spot Based COVID-19 Serology Test
-
-
-
-
-
-
-
Pre-Open Stock Movers 1/28: (DLPH) (XLRN) (ALKS) Higher (EROS) (BWA) (DDD) Lower (more...)
-
322,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

